Novartis is a pharmaceuticals, consumer health, generics, eye-care, and animal health company. Its main business units are Pharmaceuticals, Vaccines and Diagnostics, Sandoz and Consumer Health.
The Pharmaceuticals business remains its biggest and most profitable business. Strong growth was shown by the cardiovascular and oncology franchises. However, it sees its main challenge as ‘keeping a sharp eye on the market evolution’.
Novartis has a strategy of consistent investment in R&D, enabling it to bring to market innovative and differentiated products that offer patients clear therapeutic benefits. It is expanding its generics business to provide affordable treatment options following patent expiries and it is developing promising new growth platforms such as vaccines to reduce healthcare costs through disease prevention.
Download the The ICIS Top 100 Chemical Companies listing here